GlaxoSmithKline PLC Logo

GlaxoSmithKline PLC

A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.

GSK | IL

Overview

Corporate Details

ISIN(s):
GB00BN7SWP63 (+1 more)
LEI:
5493000HZTVUYLO1D793
Country:
United Kingdom
Address:
79 NEW OXFORD STREET, WC1A 1DG LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GSK is a global biopharmaceutical company that unites science, technology, and talent to prevent and treat disease. The company focuses on the discovery, development, and manufacturing of innovative vaccines and specialty medicines. Its core research and development efforts are concentrated in four therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Formed in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham, GSK has since sharpened its focus on biopharmaceuticals, notably after the 2022 demerger of its consumer healthcare business. The company is committed to improving global health by making its products accessible and affordable worldwide through strategic partnerships and access programs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-03 08:00
Transaction in Own Shares
Transaction in Own Shares
English 1.2 MB
2025-10-02 08:00
Transaction in Own Shares
Transaction in Own Shares
English 1.1 MB
2025-10-01 16:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 5.3 KB
2025-10-01 08:00
Transaction in Own Shares
Transaction in Own Shares
English 636.6 KB
2025-09-29 08:00
Board/Management Information
GSK appoints CEO designate
English 29.1 KB
2025-09-22 16:30
Director's Dealing
Director/PDMR Shareholding
English 76.7 KB
2025-09-19 08:00
Transaction in Own Shares
Transaction in Own Shares
English 183.8 KB
2025-09-18 08:00
Transaction in Own Shares
Transaction in Own Shares
English 1.6 MB
2025-09-17 08:00
Regulatory News Service
GSK US Investment Announcement
English 19.9 KB
2025-09-17 08:00
Transaction in Own Shares
Transaction in Own Shares
English 705.5 KB
2025-09-16 08:00
Transaction in Own Shares
Transaction in Own Shares
English 2.6 MB
2025-09-15 08:00
Transaction in Own Shares
Transaction in Own Shares
Japanese 2.0 MB
2025-09-11 08:00
Transaction in Own Shares
Transaction in Own Shares
English 653.1 KB
2025-09-10 16:30
Director's Dealing
Director/PDMR Shareholding
English 91.7 KB
2025-09-10 08:00
Transaction in Own Shares
Transaction in Own Shares
English 423.3 KB

Automate Your Workflow. Get a real-time feed of all GlaxoSmithKline PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GlaxoSmithKline PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy FF
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan 4554
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan 4538
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea 220100
Future Medicine  Co., Ltd. Logo
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
South Korea 341170
Develops long-acting injectable therapies for chronic diseases and cancer.
South Korea 456160
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.